Also, in a study involving a large homogeneous cohort of patients with resected pancreatic cancer, S100A2 expression was strongly associated with better OS and RFS in patients who received adjuvant treatment, whereas no statistical trend was observed in patients treated with surgery alone12. This evidence concerns the gene S100A2 and pancreatic neoplasm.